Alzheimer's Disease Trial, Recruiting NCT06094192 Sponsor: Boston University Charles River Campus Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06094192
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between the ages of 50 and 100 years old
  • People diagnosed with mild Alzheimer's disease dementia, based on standard medical criteria, with memory and at least one other area of thinking (such as language or problem-solving) being notably affected
  • People diagnosed with Mild Cognitive Impairment (MCI) thought to be due to Alzheimer's disease, based on standard medical criteria, with some memory difficulties but still able to manage daily activities independently
  • People who are healthy (no dementia or cognitive impairment) and are a similar age, education level, and gender to the Alzheimer's patients in the study
  • People with certain ongoing health conditions that are permitted, including mild depression or anxiety (not requiring hospitalisation), high cholesterol, high blood pressure, heart disease, asthma, acid reflux, thyroid conditions (treated), skin conditions, or eye conditions
  • People currently taking certain medications, including antidepressants (SSRIs), cholesterol medications, blood pressure medications, thyroid medications, aspirin, vitamins, eye drops, and some others (confirm with trial site for full list)
  • People with normal vision or vision that is fully corrected with glasses or contact lenses
  • People who are not pregnant
  • People who do not have metal implants in their head or any implanted electronic devices
  • People without skin sensitivity or claustrophobia

Who may not be able to join:

  • People who have previously had a stroke, traumatic brain injury, or any other brain or body condition that has permanently affected their thinking or memory
  • People currently taking medications not listed as permitted (confirm with trial site)
  • People who are pregnant
  • People who have metal implants in their head or implanted electronic devices (such as a pacemaker)
  • People with skin sensitivity that could be affected by the study equipment
  • People with claustrophobia
  • People with significant vision or hearing problems that would prevent them from understanding the consent process or completing the study tasks
  • People who are unable to understand the informed consent forms or the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (617) 353-9481

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston University Charles River Campus
Registry
ClinicalTrials.gov
Start date
20 December 2023
Est. completion
31 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Memory performance (active stimulation condition); Memory performance (sham stimulation condition)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov